Literature DB >> 11594450

Chemokine expression and viral infection of the central nervous system: regulation of host defense and neuropathology.

M T Liu1, T E Lane.   

Abstract

An effective host response against viral infection of the central nervous system (CNS) is the principal factor dictating the outcome of infection. It is the responsibility of the immune response to contain and control viral replication. Paradoxically, it is the immune response that may also contribute to the development of neuropathology. We have used mouse hepatitis virus (MHV), apositive-strand RNA virus, infection of the CNS to understand the dynamic interaction between viral replication, protection, and pathology with an emphasis on understanding how chemokines participate in these interrelated processes. Herein, we demonstrate the complexity of the chemokine response to MHV infection of the CNS and the delicate balance that exists between host defense and development of disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594450      PMCID: PMC7090560          DOI: 10.1385/IR:24:2:111

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  34 in total

1.  Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis.

Authors:  V C Asensio; I L Campbell
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 2.  Chemokines and T lymphocytes: more than an attraction.

Authors:  S G Ward; K Bacon; J Westwick
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

3.  CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10.

Authors:  W E Biddison; W W Cruikshank; D M Center; C M Pelfrey; D D Taub; R V Turner
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

4.  Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus.

Authors:  T E Lane; A D Paoletti; M J Buchmeier
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig.

Authors:  L Piali; C Weber; G LaRosa; C R Mackay; T A Springer; I Clark-Lewis; B Moser
Journal:  Eur J Immunol       Date:  1998-03       Impact factor: 5.532

6.  Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections.

Authors:  D J Theil; I Tsunoda; J E Libbey; T J Derfuss; R S Fujinami
Journal:  J Neuroimmunol       Date:  2000-04-03       Impact factor: 3.478

7.  Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis.

Authors:  P D Murray; K Krivacic; A Chernosky; T Wei; R M Ransohoff; M Rodriguez
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

8.  Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES.

Authors:  T J Schall; K Bacon; K J Toy; D V Goeddel
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

9.  The protective role of cytotoxic T cells and interferon against coronavirus invasion of the brain.

Authors:  E Lavi; Q Wang
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

10.  Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo.

Authors:  B D Pearce; M V Hobbs; T S McGraw; M J Buchmeier
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more
  10 in total

Review 1.  Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.

Authors:  Susan R Weiss; Sonia Navas-Martin
Journal:  Microbiol Mol Biol Rev       Date:  2005-12       Impact factor: 11.056

2.  Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis.

Authors:  Talibah U Metcalf; Victoria K Baxter; Voraphoj Nilaratanakul; Diane E Griffin
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

Review 3.  Animal modeling of lower urinary tract dysfunction associated with multiple sclerosis: Part I: Justification of the mouse model for MS research.

Authors:  Ramalakshmi Ramasamy; Phillip P Smith
Journal:  Neurourol Urodyn       Date:  2021-03-14       Impact factor: 2.696

4.  Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis.

Authors:  Jun Xu; Shuqing Zhong; Jinghua Liu; Li Li; Yong Li; Xinwei Wu; Zhijie Li; Peng Deng; Jingqiang Zhang; Nanshan Zhong; Yanqing Ding; Yong Jiang
Journal:  Clin Infect Dis       Date:  2005-09-12       Impact factor: 9.079

5.  Differential regulation of innate and adaptive immune responses in viral encephalitis.

Authors:  Julia D Rempel; Shannon J Murray; Jeffrey Meisner; Michael J Buchmeier
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

Review 6.  Murine-β-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2.

Authors:  Debanjana Chakravarty; Jayasri Das Sarma
Journal:  J Neurovirol       Date:  2021-02-05       Impact factor: 2.643

Review 7.  Spike Glycoprotein Is Central to Coronavirus Pathogenesis-Parallel Between m-CoV and SARS-CoV-2.

Authors:  Fareeha Saadi; Debnath Pal; Jayasri Das Sarma
Journal:  Ann Neurosci       Date:  2021-10-12

8.  Experimental coronavirus retinopathy (ECOR): retinal degeneration susceptible mice have an augmented interferon and chemokine (CXCL9, CXCL10) response early after virus infection.

Authors:  Barbara Detrick; Maria Teresa Lee; Marian S Chin; Laura C Hooper; Chi-Chao Chan; John J Hooks
Journal:  J Neuroimmunol       Date:  2007-11-26       Impact factor: 3.478

Review 9.  Pathogenesis of flavivirus encephalitis.

Authors:  Thomas J Chambers; Michael S Diamond
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

10.  Mouse hepatitis virus pathogenesis in the central nervous system is independent of IL-15 and natural killer cells.

Authors:  Jun Zuo; Stephen A Stohlman; Jason B Hoskin; David R Hinton; Roscoe Atkinson; Cornelia C Bergmann
Journal:  Virology       Date:  2006-02-28       Impact factor: 3.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.